Genomic diversity of multidrug-resistant Rhodococcus equi: novel sequence types, pangenome architecture, and phylogenomic evolution.

This study sequenced and tested 46 Rhodococcus equi isolates from Kentucky horses to map their antibiotic resistance, virulence traits, and evolutionary relationships. It found many multidrug-resistant strains, widespread virulence features, and numerous previously unknown genetic lineages that overlap with human- and animal-associated strains, indicating One Health risks.

What the researchers asked and why it matters

• Question: How diverse are contemporary R. equi populations circulating on equine farms, what is their burden of antimicrobial resistance (AMR), and how are virulence and resistance organized across the genome?
• Importance: R. equi causes severe pneumonia in foals and opportunistic infections in immunocompromised people; understanding its resistance and evolutionary dynamics informs treatment, surveillance, and cross-species risk assessment.

Study design and sample set

• Setting: Equine farm systems in Kentucky, USA.
• Timeframe: January 2022 to December 2023.
• Samples: 46 isolates—45 from horses submitted for necropsy and 1 from equine feces.
• Approach: Combined phenotypic assays (antimicrobial susceptibility, biofilm formation, intracellular survival) with whole-genome sequencing (WGS) and comparative genomics.

Laboratory and genomic methods used

• Antimicrobial susceptibility testing to identify resistance profiles, including rifamycin, macrolides, tetracyclines, sulfonamides, and cephalosporins.
• Biofilm assays to quantify ability to form robust surface-adherent communities.
• Macrophage survival assays to assess intracellular persistence, a hallmark of R. equi pathogenesis.
• Detection of canonical virulence determinants, including vapA, vapH, and iupT.
• Multilocus sequence typing (MLST) to define sequence types (STs) and lineage structure.
• Pangenome analysis to partition core versus accessory genes and infer genome fluidity.
• Phylogenomic analysis to contextualize isolates relative to strains from humans and other animals.

Key findings: Antimicrobial resistance landscape

• High burden of multidrug resistance (MDR): 32.6% of isolates (approximately 15/46) were MDR.
• Resistant classes included rifamycin, macrolides, tetracyclines, sulfonamides, and cephalosporins, indicating limited therapeutic options if standard regimens fail.
• Implication: The breadth of resistance across multiple first-line classes raises the risk of treatment failure in foals and complicates empirical therapy.

Key findings: Virulence traits and biofilms

• Biofilm formation was nearly universal: 97.8% (about 45/46) formed robust biofilms.
• Intracellular survival in macrophages was common, aligning with known R. equi pathogenic mechanisms.
• Virulence determinants were conserved: most isolates carried vapA, vapH, and iupT, supporting pathogenic potential across diverse lineages.
• Implication: Convergence of MDR with strong biofilm capacity and intracellular survival likely increases persistence and treatment difficulty.

Genomic population structure: MLST and novel lineages

• MLST identified 22 sequence types among 46 isolates, reflecting substantial diversity within a single regional and temporal window.
• Twenty of these STs were novel, indicating ongoing lineage expansion and underappreciated diversity in equine-associated populations.
• Implication: Routine surveillance likely misses considerable circulating diversity; outbreak tracing and epidemiology require high-resolution genomics.

Pangenome architecture

• Large accessory genome with limited core gene conservation, consistent with genomic plasticity and adaptation across niches.
• Interpretation: A sizeable accessory gene pool facilitates rapid acquisition of resistance and niche-specific traits, likely via horizontal gene transfer and recombination.
• Clinical relevance: Adaptive accessory elements can disseminate resistance and virulence across distinct lineages, undermining narrow lineage-focused control strategies.

Phylogenomics and One Health signal

• Phylogenomic clustering placed Kentucky horse isolates alongside strains from humans and other animal hosts.
• Interpretation: Shared evolutionary ancestry and possible cross-species transmission or exposure to common environmental reservoirs.
• One Health perspective: Farm environments may serve as hubs where resistance and virulence circulate among animals, environmental bacteria, and occasionally humans.

What these results mean

• Therapeutic challenge: Co-occurrence of MDR with strong biofilm and intracellular survival suggests higher risk of refractory infections and prolonged treatment courses.
• Evolutionary dynamics: Discovery of numerous novel STs alongside a large accessory genome indicates active diversification and gene flow within farm-associated R. equi.
• Public health relevance: Genetic relatedness to human isolates raises concern for spillover into immunocompromised individuals and underscores environmental oversight.
• Management implication: Stewardship and infection control must address both antibiotic pressure and environmental reservoirs that facilitate transmission and gene exchange.

Strengths and limitations

• Strengths:
  • Integrated phenotypic and genomic approach links resistance, virulence, and lineage context.
  • High-resolution WGS enables discovery of numerous previously unreported STs.
  • Functional assays (biofilm, macrophage survival) anchor genomic findings to pathogenic behaviors.
• Limitations:
  • Geographic focus on a single U.S. state may limit generalizability.
  • Sampling dominated by necropsy submissions could bias toward more severe disease presentations.
  • Moderate sample size (n = 46) and two-year window constrain detection of temporal trends.
  • Lack of detailed treatment histories or farm-level metadata may obscure drivers of MDR emergence.

Practical implications for veterinary and public health practice

• Antimicrobial stewardship:
  • Reassess empirical protocols for foal pneumonia in regions with demonstrated MDR.
  • Favor culture-guided therapy and minimize prolonged combination regimens when not indicated.
• Biosecurity and environmental control:
  • Mitigate dust and manure aerosolization on farms; optimize hygiene to reduce environmental load.
  • Isolate affected foals when feasible to reduce within-farm spread.
• Genomic surveillance:
  • Incorporate WGS and MLST into routine monitoring to track emerging STs and resistance gene flow.
  • Share genomic data across veterinary and public health networks to detect cross-species links.
• Therapeutic innovation:
  • Explore alternative strategies (e.g., anti-biofilm approaches, immunomodulation, vaccine development) alongside optimized antibiotic regimens.

Future research directions

• Map mobile genetic elements and resistance determinants within the accessory genome to clarify transmission pathways.
• Longitudinal farm-level studies to link antimicrobial use, environmental factors, and emergence of MDR lineages.
• Host-pathogen interaction studies to dissect how conserved vap genes and biofilm traits drive disease severity.
• Expanded, multi-region sampling—including human clinical isolates—to refine One Health risk assessments.

Bottom line

• R. equi circulating in Kentucky equine systems shows widespread virulence, substantial multidrug resistance, and remarkable genomic diversity, including many novel lineages.
• These features, coupled with phylogenomic links to human and animal strains, position R. equi as a One Health concern and justify enhanced stewardship, surveillance, and development of alternative interventions.